Clinical Trial Update: Olive Leaf Extracts in the Control of Cardiovascular Risk [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating olive leaf extracts for cardiovascular risk management in type 2 diabetes and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Olive Leaf Extracts (olive leaf extract)

Snippet

Sponsor: University of Monastir | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 2, Phase 3 | Status: UNKNOWN